👋🏻 Hola, Barcelona! The #QuibimTeam is here at #ESMO2024, ready to engage with all of you who are part of the global oncology and healthcare community. Visit us at Booth #526 to meet our team or book a demo to discover our latest medical imaging solutions here: https://lnkd.in/dhMgFu_2 #OncologyCare #CancerCare #PrecisionMedicine
An NHS review report has been published today with the aim of identifying points for improvement. The report is the result of a nine-week review conducted by independent expert and NHS surgeon Lord Darzi. With the findings in mind, our CEO and Co-Founder Ángel Alberich-Bayarri makes the following statement: “𝘘𝘶𝘪𝘣𝘪𝘮 𝘸𝘦𝘭𝘤𝘰𝘮𝘦𝘴 𝘓𝘰𝘳𝘥 𝘋𝘢𝘳𝘻𝘪 𝘰𝘧 𝘋𝘦𝘯𝘩𝘢𝘮'𝘴 𝘳𝘦𝘱𝘰𝘳𝘵 𝘢𝘯𝘥 𝘬𝘦𝘺 𝘧𝘪𝘯𝘥𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘵𝘩𝘦 𝘕𝘏𝘚 𝘯𝘦𝘦𝘥𝘴 𝘵𝘰 𝘦𝘮𝘣𝘳𝘢𝘤𝘦 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯, 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 𝘵𝘩𝘦 𝘶𝘴𝘦 𝘰𝘧 𝘣𝘪𝘨 𝘥𝘢𝘵𝘢 𝘴𝘦𝘵𝘴 𝘢𝘯𝘥 #𝘈𝘐 𝘵𝘰 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴. 𝘈𝘐, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘪𝘵𝘴 𝘢𝘱𝘱𝘭𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘪𝘮𝘢𝘨𝘪𝘯𝘨, 𝘤𝘢𝘯 𝘢𝘯𝘥 𝘴𝘩𝘰𝘶𝘭𝘥 𝘱𝘭𝘢𝘺 𝘢 𝘤𝘦𝘯𝘵𝘳𝘢𝘭 𝘳𝘰𝘭𝘦 𝘪𝘯 𝘵𝘩𝘦 𝘥𝘦𝘵𝘦𝘤𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴 𝘰𝘧 𝘤𝘢𝘯𝘤𝘦𝘳 𝘢𝘯𝘥 𝘰𝘵𝘩𝘦𝘳 𝘥𝘪𝘴𝘦𝘢𝘴𝘦𝘴, 𝘢𝘴 𝘸𝘦𝘭𝘭 𝘢𝘴 𝘪𝘯 𝘥𝘳𝘶𝘨 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘤𝘳𝘪𝘵𝘪𝘤𝘢𝘭 𝘤𝘢𝘳𝘦 𝘥𝘦𝘭𝘪𝘷𝘦𝘳𝘺, 𝘪𝘮𝘱𝘳𝘰𝘷𝘪𝘯𝘨 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴.” https://lnkd.in/db-Cbc_B
📝 A must-read before hashtag#ESMO2024: As we approach one of the major oncology events of the year, we wanted to reflect on the evolving #OncologyCare landscape with this interview with Oscar Juan, MD, Phd, thoracic medical oncologist. Whether you are a clinician, researcher or healthcare professional, this post offers valuable insights as you look ahead to the congress ⬇️ https://lnkd.in/dkaBGnxe #PrecisionMedicine #HealthInnovation
📊 Last week we asked you about the potential of radiomics in #healthcare. Many of you recognize the value of radiomics in improving #PatientCare and increasing efficiency in drug development, consistent with the latest trends observed in the industry. 🎯 Radiomics is taking center stage in Precision Medicine. With 40 #ASCO2024 abstracts discussing its applications, it is clear that this technology is having a significant impact. Scroll through the carousel to learn more about this topic ⬇ #Radiomics #PrecisionMedicine #HealthInnovation
During #ProstateHealthAwarenessMonth, it is important to highlight that while prostate screening is crucial to saving lives, it continues to present numerous needs. The effectiveness of prostate cancer imaging depends on sensitivity, which is essential for accurate diagnosis, effective treatment planning, and improved patient outcomes. The QP-Prostate® imaging tool, the only one trained with both systematic and targeted biopsies increases sensitivity from 79.8% up to 90.4%, and significantly enhances the detection of #ProstateCancer, with the goal of reducing mortality and improving patients' quality of life. #ProstateCancer #ProstateHealth #MensHealth
The path to bringing a new drug to market is challenging: costly trials, lengthy timelines, and the risk of failure due to poor patient selection and limited biomarker #data. 𝗛𝗼𝘄 𝗰𝗮𝗻 𝗤𝗣-𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗵𝗲𝗹𝗽? ➡ Smarter Patient Selection ➡ Non-Invasive Monitoring ➡ Comprehensive Biomarkers ➡ Efficient Trials Ready to enhance your drug development process? Download our infographic dashboards for a deeper look: https://lnkd.in/dbCRz9SK #DrugDevelopment #AIinHealthcare #MedicalImaging #ESMO2024
Clinicians are sometimes faced with some limitations that lead to misdiagnosis and patient uncertainty. QP-Prostate® - the only tool trained with both systematic and targeted biopsies - addresses this problem by increasing sensitivity from 79.8% up to 90.4%. See how QP-Prostate® can improve your practice: book a demo with our team today! https://lnkd.in/d67y-mqn #ProstateCancer #ProstateHealth #MensHealth #ProstateHealthAwarenessMonth
As the healthcare landscape rapidly evolves, we're eager to hear your thoughts on radiomics, a pioneering field within #PrecisionMedicine. How knowledgeable and interested do you think healthcare professionals are in radiomics? Join the conversation, and let's explore the perspectives in our field on this transformative technology! #Radiomics #AIInHealth #InnovationInHealth #Quibim
August saw a lot of interesting news and inspiring conversations. Here are some of them: 🌎 A blog on how we align our innovations with global sustainability goals. ✅ The key considerations in selecting the right AI solutions to improve patient outcomes. 🏥 A critical debate on population-based screening for prostate cancer, highlighting current solutions to make testing more affordable and accessible lead by Prof. Dr. Shonit Punwani from UCL. 💻 QP-Prostate® used by experts in real-world scenarios. 🔊 The announcement of our activities and contributions as we get ready for the ESMO - European Society for Medical Oncology conference. Stay up to date on the latest developments in #patientcare, #medicalimaging and #radiology in our monthly newsletter. Sign up to be updated!
🗓️ In two weeks, from September 13-17, our #QuibimTeam will be in Barcelona for the world-leading oncology event: #ESMO2024! 👋🏻 Say hi to booth #526 and discover through our market-approved solution QP-Insights® the latest advancements in #oncology, medical imaging, and #PatientCare. https://lnkd.in/dirKEMU8 #cancercare
